Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCALATE: Protocolized Diuretic Therapy vs Standard Care in Acute Heart Failure
NCT04481919Phase 2Active, not recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2022
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Acute Heart Failure (AHF) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Clinical Status Score at 14 days. Started May 2022; status: active, not recruiting.
02
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT04481919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04481919.